Triple-negative breast cancers express receptors for growth hormone-releasing hormone (GHRH) and respond to GHRH antagonists with growth inhibition.

Source:http://linkedlifedata.com/resource/pubmed/id/18629632

Download in:

View as

General Info

PMID
18629632